CD8A and neoplasm: A recent study showed that targeted radionuclide therapy can render immunologically cold syngeneic B78 melanoma tumors sensitive to ICIs.347 Researchers observed a significant increase in tumor-infiltrating myeloid (CD11b+), and NK cells and an increase in the ratio of effector CD8+ to suppressor Treg cells after low-dose RT.